Thursday, April 9, 2026
spot_img

These are Barclays’ top defensive stocks. They also pay solid dividends

Navigating Persistent Market Volatility: Barclays Highlights Defensive Stock Picks

Global financial markets are grappling with a new normal where geopolitical tensions, technological disruption, and sector-specific risks are no longer temporary shocks but enduring features of the investment landscape. This sobering assessment comes from analysts at Barclays, who note that recent market turbulence—including the Dow Jones Industrial Average entering correction territory and the S&P 500 recording its fifth consecutive weekly loss—requires a strategic shift for investors. According to Andrew Ferremi, a Barclays analyst, the confluence of factors like the ongoing Iran conflict, AI-driven sector disruption, and stresses in the private credit market has created a complex environment where traditional risk-on strategies may falter.

In response, Barclays’ sector analysts have identified a slate of stocks that combine defensive characteristics with strong analyst ratings. These picks are not merely about weathering storms; many also offer attractive income through dividends and are positioned to benefit from longer-term structural trends. The firm’s research emphasizes companies with robust balance sheets, resilient business models, and, in some cases, technological advantages that can enhance operational efficiency.

Extra Space Storage: A High-Yield REIT with Tech-Enhanced Resilience

Topping the list is Extra Space Storage (ticker: EXR), a real estate investment trust (REIT) specializing in self-storage facilities. Analyst Brendan Lynch highlights the sector’s historical resilience through economic cycles, noting that easing supply pressures are expected to improve financial fundamentals further. The stock currently offers a yield of approximately 5%, the highest on Barclays’ list. Importantly, Lynch points to artificial intelligence as a potential tailwind, enabling larger players like Extra Space to leverage vast customer data for enhanced marketing and dynamic pricing. With a price target of $170, Barclays sees nearly 32% upside from recent levels, despite the stock being roughly flat year-to-date.

JPMorgan Chase: A Fortress Balance Sheet in the Financial Sector

Among financial institutions, JPMorgan Chase (ticker: JPM) is singled out as a premier defensive bank. Despite being down more than 11% in 2026, the stock provides a 2.1% dividend yield, offering investors compensation while awaiting potential recovery. Analyst Jason Goldberg attributes its strength to one of the sector’s most robust balance sheets and a uniquely diversified, global franchise. He describes its business model as “complete, global, diversified, and at scale,” attributes that support stable earnings across environments and help offset margin compression. Goldberg’s $391 price target implies a significant 38% potential upside from Friday’s closing price.

Coca-Cola: The Quintessential Defensive Staples Leader

Coca-Cola (ticker: KO) is described by analyst Lauren Lieberman as “the best example of a truly defensive, high-quality Staples business.” The beverage giant’s portfolio of iconic brands provides consistent demand regardless of economic conditions, and its long-standing operational flexibility allows it to navigate dynamic macroeconomic climates while targeting specific growth opportunities. The stock, up nearly 10% year-to-date, pays a 2.8% dividend yield. Barclays’ $83 price target suggests approximately 10% additional upside, reflecting confidence in its enduring defensive qualities.

Merck & Co.: A Pharma ‘Safe Haven’ Amid Macro Uncertainty

In the healthcare sector, Merck & Co. (ticker: MRK) is viewed as a “safe haven” for investors seeking refuge during periods of macroeconomic uncertainty. Analyst Emily Field points to the pharmaceutical company’s stable demand profile and strong pipeline as key protective factors. The stock, which has already gained about 11% in 2026, offers a 2.9% dividend yield. With a price target of $140, Field sees roughly 17% room for further appreciation, underscoring its appeal as a defensive healthcare holding.

Collectively, these recommendations from Barclays underscore a tactical pivot toward quality, income, and resilience. Investors are not being advised to retreat entirely from markets but to recalibrate portfolios toward companies with fortress-like financials, essential products or services, and management teams experienced in navigating volatility. As Ferremi’s initial note warns, the current environment demands that investors treat geopolitical and structural disruption as permanent considerations—not passing storms—making these types of defensive, well-capitalized positions a prudent core holding for choppy times ahead.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_imgspot_img
spot_img

Hot Topics

Related Articles